Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

COVID 2024 Surge: The Most Accessible Defense

MedCram

R. Seheult

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

Project 2025 vs. the Public's Health Part II: The FDA

MicrobeTV

P. Offit, V. Racaniello

What's New with COVID in 2024?

Michigan Medicine

L. Washer

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

ACAAI 2024 Insights: Secondary Immunodeficiency - Management Strateg…

ACAAI 2024 Insights

S. Mustafa

Preventing Complications with Vaccines in Persons with Diabetes (PWD)

Allison Presnell

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Monkeypox Declared a Public Health Emergency of International Concer…

MicrobeTV

D. Griffin, V. Racaniello

Vaccines for Adults: COVID, RSV, Influenza and More

Michigan Medicine

L. Washer

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

H5N1 Outbreak: Are We Inching Closer to Human Transmissibility?

MedCram

R. Seheult

Project 2025 vs. The Public’s Health: What is Project 2025? What is …

MicrobeTV

P. Offit, V. Racaniello

IDWeek 2024 Insights: COVID-19 in Children - Navigating the Current …

IDWeek 2024 Insights

I. Anosike

Unveiling the Facets of Post-Sepsis Syndrome: Physical and Neuropsyc…

Houston Methodist

D. Moran

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan